|
SPRED1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.567500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059880E-02 |
| Normal-vs-Stage2 |
6.100100E-02 |
| Normal-vs-Stage3 |
5.381200E-01 |
| Normal-vs-Stage4 |
8.913200E-01 |
| Stage1-vs-Stage2 |
7.300000E-01 |
| Stage1-vs-Stage3 |
2.293800E-02 |
| Stage1-vs-Stage4 |
1.756330E-02 |
| Stage2-vs-Stage3 |
1.216380E-01 |
| Stage2-vs-Stage4 |
7.712100E-02 |
| Stage3-vs-Stage4 |
6.462600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626650E-01 |
| Normal-vs-AfricanAmerican |
9.279800E-03 |
| Normal-vs-Asian |
2.856400E-01 |
| Caucasian-vs-AfricanAmerican |
9.470000E-02 |
| Caucasian-vs-Asian |
9.109200E-01 |
| AfricanAmerican-vs-Asian |
1.071020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.027900E-02 |
| Normal-vs-Female |
4.358100E-02 |
| Male-vs-Female |
8.985400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.676600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.287230E-01 |
| Normal-vs-Age(61-80Yrs) |
5.759800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.362000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.670000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.320310E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.523400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.876800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.570200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.121130E-03 |
| Classical-VS-Follicular |
3.703800E-02 |
| Classical-VS-Other |
9.978600E-01 |
| Classical-VS-Normal |
6.823700E-02 |
| Tall-VS-Follicular |
7.74450000000648E-05 |
| Tall-VS-Other |
2.852400E-01 |
| Tall-VS-Normal |
3.536600E-01 |
| Follicular-VS-Other |
5.139600E-01 |
| Follicular-VS-Normal |
2.004500E-03 |
| Other-VS-Normal |
4.330000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.551500E-02 |
| Normal-vs-N1 |
4.418000E-01 |
| N0-vs-N1 |
3.676800E-01 |
|
|
